Having trouble accessing articles? Reset your cache.

SB1317: Phase I started

Tragara began an open-label, dose-ranging, U.S. Phase I trial

Read the full 98 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE